Lucid Diagnostics (LUCD) Research & Development (2020 - 2026)

Lucid Diagnostics has reported Research & Development for 7 years, with the latest figure at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 15.55% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (down 7.82% YoY), and the FY2025 full-year result was $5.7 million, down 5.24% from the prior year.
• Research & Development for Q1 2026 stood at $1.2 million, down from $1.7 million in the prior quarter.
• The five-year high for Research & Development was $3.4 million in Q2 2022, with the low at $1.2 million in Q1 2026.
• Historically, Research & Development has averaged $1.9 million across 5 years, with a median of $1.7 million in 2024.
• Annual changes were most pronounced in 2022 — Research & Development surged 83.66% — and 2023, when it plunged 46.89%.
• Lucid Diagnostics' Research & Development stood at $2.4 million in 2022, then declined by 21.46% to $1.9 million in 2023, then declined by 24.24% to $1.5 million in 2024, then increased by 18.58% to $1.7 million in 2025, then tumbled by 30.01% to $1.2 million in 2026.
• The last three Research & Development figures came in at $1.2 million (Q1 2026), $1.7 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.